Endogenous tumor necrosis factor and doxorubicin sensitivity in leukemic patients

Leukemia and Lymphoma

Volumn 30, Issue 5-6, 1998, Pages 477-482

  Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Doxorubicin; Drug sensitivity; Endogenous tumor necrosis factor; Leukemia; Manganous superoxide dismutase

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; MANGANESE SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DNA TRANSFECTION; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031822777     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057560     Document Type: Article

References (28)

1. Bradley, G., Juranka, P. F. and Ling, V. (1988). Mechanism of multidrug resistance. Biochim. Biophys. Acta., 948, 87-128.
2. Krishan, A., Sauerteig, A. and Wellham, L. L. (1985). Flow cytometric studies on modulation of cellular adriamycin retention by phenothiazines. Cancer Res., 45, 1046-1051.
3. Deffie, A. M., Alam, T., Seneviratne, C., Beenken, S. W., Batra, J. K., Shea, T. C., Henner, W. D. and Goldenberg, G. J. (1988). Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and p-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res., 48, 3595-3602.
4. Fruehauf, J. P., Mimnaugh, E. G. and Sinha, B. K. (1991). Doxorubicin-induced cross-resistance to tumor necrosis factor (TNF) related to differential TNF processing. J. Immunotherapy. 10, 165-173.
5. Maeda, M., Watanabe, N., Okamoto, T., Tsuji, N. and Niitsu, Y. (1994). Endogenous tumor necrosis factor functions as a resistant factor against adriamycin. Int. J. Cancer, 58, 376-379.
6. Niitsu, Y., Watanabe, N., Neda, H., Yamauchi, N., Maeda, M., Sone, H. and Kuriyama, H. (1988). Induction of synthesis of tumor necrosis factor in human and murine cell lines by exogenous recombinant human tumor necrosis factor. Cancer Res., 48, 5407-5410.
7. Himeno, T., Watanabe, N., Yamauchi, N., Maeda, M., Tsuji, Y., Okamoto, T., Neda, H. and Niitsu, Y. (1990). Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res., 50, 4941-4945.
8. Okamoto, T., Watanabe, N., Yamauchi, N., Tsuji, Y., Tsuji, N., Itoh, Y., Neda, H. and Niitsu, Y. (1992). Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res., 52, 5278-5281.
9. Tsuji, Y., Watanabe, N., Okamoto, T., Tsuji, N., Sasaki, H., Akiyama, S., Yamauchi, N. and Niitsu, Y. (1992). Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity. Cancer Res., 52, 6258-6262.
10. Yamauchi, N., Kuriyama, H., Watanabe, N., Neda, H., Maeda, M. and Niitsu, Y. (1989). Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res., 49, 1671-1675.
11. Yamauchi, N., Watanabe, N., Kuriyama, H., Neda, H., Maeda, M., Himeno, T., Tsuji, Y. and Niitsu, Y. (1990). Suppressive effects of intracellular glutathione on hydroxyl radical production induced by tumor necrosis factor. Int. J. Cancer, 46, 884-888.
12. Himeno, T., Watanabe, N., Yamauchi, N., Okamoto. T., Tsuji, N., Tsuji, Y., Akiyama, S., Sasaki, H. and Niitsu, Y. (1992). Induction of synthesis of manganous superoxide dismutase in L-M(PNTNF) cells carrying an inducible TNF gene. Int. J. Cancer, 50, 1-5.
13. Kobayashi, D., Watanabe, N., Yamauchi, N., Tsuji, N., Sato, T. and Niitsu, Y. (1997). Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood, 89, 2472-2479.
14. Chao, C. C. K., Huang, Y. T., Chang, M. M. A., Chou, W. Y. and Chao, S. L. (1991). Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line. Mol. Pharmacol., 41, 69-75.
15. Nakagawa, K., Saijo, N., Tsuchida, S., Sasaki, M., Tsunokawa, Y., Yokota, J., Muramatsu, M., Sato, K., Terada, M. and Tew, K. D. (1990). Glutathione S-transferase π as a determinant of drug resistance in transfectant cell lines. J. Biol. Chem., 265, 4296-4301.
16. Hao, X. Y., Bergh, J., Brodin, O., Hellman, U. and Mannervik, B. Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes. Carcinogenesis. 15, 1167-1173.
17. Tidefelt, U., Rosenborg, A. E., Paul, C., Hao, X. Y., Mannervik, B. and Eriksson, L. C. (1992). Expression of glutathione transferase π as a predictor for treatment results at dirrerent stages of acute nonlymphoblastic leukemia. Cancer Res., 52, 3281-3285.
18. Hall, A., Foster. S., Proctor. S. J. and Cattan. A. R. (1990). Purification and characterization of a pi class glutathione S-transferase from human leukaemic cells. Br. J. Haematol., 76, 494-500.
19. 6-alkylguanine-DNA-alkyltransferase and p-glycoprotein in adult patients with leukaemia. Br. J. Haematol., 85, 103-111.
20. Slapak, C. A., Mizunuma, N. and Kufe, D. W. (1944). Expression of the multidrug resistance associated protein and p-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood, 84, 3113-3121.
21. Baer, M. R. and Bloomfield, C. D. (1991). Multidrug resistance in acute myeloid leukemia. J. Natl, Cancer Invest., 83, 663-665.
22. Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M. and Deeley, R.G. (1994). Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54, 5902-5910.
23. Zaman, G. J. R., Flens, M. J., Leusden, M. R., Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J. and Borst, P. (1994). The human multidrug resistance -associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci, U.S.A., 91, 8822-8826.
24. Zyad, A., Benard, J., Tursz, T., Clarke, R. and Chouaib, S. (1994). Resistance to TNF-α and adriamycin in the human breast cancer MCF-7 cell line: Relationship to MDR1, MnSOD, and TNF gene expression. Cancer Res., 54, 825-831.
25. Meijer, C., Mulder, N. H., Bosscha, H. T., Zijlstra, J. G. and Vries, E. G. E. (1987). Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line. Cancer Res., 47, 4613-4617.
26. Doroshow, J. H. (1986). Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc. Natl. Acad. Sci, U.S.A., 83, 4514-4518.
27. Bann, N., Takahashi, Y., Takayama, T., Kura, T., Katahira, T., Sakamaki, S. and Niitsu, Y. (1996). Transfection of glutathione s-transferase (GST)-π antisense cDNA increases sensitivity of colon cancer cell line to adriamycin, cisplatin, melphalan and etoposide. Cancer Res., 56, 3577-3582.
28. Corrias, M. V. and Tonini, G. P. (1992). An oligomer complementary to the 5′ end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells. Anticancer Res., 12, 1431-1438.